Chia-Ching Wu Selected Research

Chia-Ching Wu Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 09/2014
6	Inflammation (Inflammations) 10/2021 - 01/2014
4	Wounds and Injuries (Trauma) 12/2023 - 01/2017
4	Hypoxia (Hypoxemia) 10/2018 - 01/2012
3	Carcinogenesis 01/2022 - 11/2018
3	Huntington Disease (Huntington's Disease) 05/2021 - 01/2018
2	Cicatrix (Scar) 01/2023 - 02/2014
2	Neuralgia (Stump Neuralgia) 01/2023 - 01/2020
2	Neuroinflammatory Diseases 01/2023 - 04/2021
2	Hypersensitivity (Allergy) 08/2019 - 08/2018
2	Ischemia 10/2018 - 05/2016
1	Hypercholesterolemia 01/2024
1	Primary hyperoxaluria type 1 01/2024
1	Amyloidosis 01/2024
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2024
1	Metabolic Diseases (Metabolic Disease) 01/2024
1	COVID-19 01/2024
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Congenital Heart Defects (Congenital Heart Defect) 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Testicular Neoplasms (Testicular Cancer) 11/2020
1	Tendinopathy (Tendonitis) 07/2020
1	Dengue (Dengue Fever) 04/2020
1	Zika Virus Infection 04/2020
1	Infections 01/2020
1	due to Sepiapterin Reductase Deficiency Dopa-Responsive Dystonia 01/2020
1	Bone Resorption 10/2019
1	Asphyxia (Suffocation) 10/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Necrosis 05/2016
1	Air Embolism (Gas Embolism) 04/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2017
4	Fibroblast Growth Factor 9IBA 05/2021 - 01/2018
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 01/2014
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2024
2	ChitosanIBA 12/2023 - 02/2014
2	Histones (Histone)IBA 01/2023 - 01/2021
2	IntegrinsIBA 09/2022 - 09/2014
2	ElastinIBA 07/2020 - 01/2019
2	AllergensIBA 08/2019 - 08/2018
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2017 - 01/2012
2	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 02/2014 - 01/2014
2	Sodium Salicylate (Salicylate, Sodium)IBA 01/2012 - 11/2008
2	sulindac sulfideIBA 01/2012 - 11/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012 - 11/2008
2	nasIBA 01/2012 - 11/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012 - 11/2008
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2012 - 11/2008
1	Prealbumin (Transthyretin)IBA 01/2024
1	Acute Hepatic PorphyriaIBA 01/2024
1	VaccinesIBA 01/2024
1	MineralocorticoidsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	GlucuronidesIBA 01/2022
1	Furosemide (Lasix)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	CytokinesIBA 10/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 10/2021
1	NF-kappa B (NF-kB)IBA 05/2021
1	OxysterolsIBA 04/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 11/2020
1	cordycepinIBA 11/2020
1	Conditioned Culture MediaIBA 08/2020
1	Collagenases (Collagenase)FDA Link 07/2020
1	EnzymesIBA 07/2020
1	Pancreatic Elastase (Elastase)IBA 07/2020
1	CollagenIBA 07/2020
1	AntibodiesIBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	peptidoglycan endopeptidaseIBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 10/2019
1	collagen type I trimeric cross-linked peptideIBA 10/2019
1	Ephrin-A1 (Ephrin A1)IBA 10/2018
1	Immunoglobulin E (IgE)IBA 08/2018
1	Pyruvate KinaseIBA 08/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018
1	CXC ChemokinesIBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 05/2016
1	Midazolam (Versed)FDA LinkGeneric 01/2016
1	CaspasesIBA 01/2016

Therapy/Procedure

8	Therapeutics 01/2024 - 05/2016
1	Rejuvenation 01/2023
1	Decompression 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2018
1	Intradermal Injections 05/2016
1	Vitrectomy 04/2015